XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 27, 2022
Mar. 28, 2021
Cash flows from operating activities:    
Net income $ 280,560 $ 100,468
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 102,142 86,532
Deferred income tax expense (benefit) (21,917) 12,483
Stock-based compensation 1,963 2,042
Loss (gain) on property disposals 1,855 (2,396)
Loan cost amortization 1,280 1,215
Accretion of discount related to Senior Notes 429 246
Loss (gain) on equity-method investments 8 (4)
Amortization of premium related to Senior Notes 0 (167)
Changes in operating assets and liabilities:    
Trade accounts and other receivables (66,669) (54,892)
Inventories (146,035) (82,550)
Prepaid expenses and other current assets (5,889) 20,228
Accounts payable, accrued expenses and other current liabilities (2,454) (240,183)
Income taxes 84,780 25,440
Long-term pension and other postretirement obligations (1,101) (10,841)
Other operating assets and liabilities (1,956) (1,172)
Cash provided by (used in) operating activities 226,996 (143,551)
Cash flows from investing activities:    
Acquisitions of property, plant and equipment (81,578) (102,167)
Purchase of acquired business, net of cash acquired (4,847) 0
Proceeds from property disposals 849 13,074
Cash used in investing activities (85,576) (89,093)
Cash flows from financing activities:    
Proceeds from revolving line of credit and long-term borrowings 228,505 328,932
Payments on revolving line of credit, long-term borrowings and finance lease obligations (32,093) (235,292)
Purchase of common stock under share repurchase plan (27,023) 0
Payment of equity distribution under Tax Sharing Agreement between JBS USA Holdings and Pilgrim’s Pride Corporation (1,961) (650)
Payments of capitalized loan costs (1,098) 0
Cash provided by financing activities 166,330 92,990
Effect of exchange rate changes on cash and cash equivalents (2,073) 1,488
Increase (decrease) in cash, cash equivalents and restricted cash 305,677 (138,166)
Cash, cash equivalents and restricted cash, beginning of period 450,121 548,406
Cash, cash equivalents and restricted cash, end of period $ 755,798 $ 410,240